oxazolidin-2-one has been researched along with Glucose Metabolic Disorder in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jia, M; Li, M; Li, Y; Pan, T; Sun, Y; Xiao, L; Xiao, Y; Zhou, L | 1 |
1 other study(ies) available for oxazolidin-2-one and Glucose Metabolic Disorder
| Article | Year |
|---|---|
Epigoitrin alleviates lipid and glucose metabolic disorders induced by a high-fat diet.
Topics: Animals; Diet, High-Fat; Glucose Metabolism Disorders; Insulin Resistance; Lipid Metabolism; Lipids; Mice; Mice, Inbred C57BL; Obesity; Oxazolidinones | 2022 |